Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells

被引:472
作者
Baratelli, F
Lin, Y
Zhu, L
Yang, SC
Heuzé-Vourc'h, N
Zeng, G
Reckamp, K
Dohadwala, M
Sharma, S
Dubinett, SM
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Lung Canc Res Program, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA
[3] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA
关键词
D O I
10.4049/jimmunol.175.3.1483
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Naturally occurring CD4(+)CD25(+) regulatory T cells (T reg) are pivotal in suppressing immune responses and maintaining tolerance. The identification of molecules controlling T reg differentiation and function is important in understanding host immune responses in malignancy and autoimmunity. In this study we show that PGE(2) enhances the in vitro inhibitory function of human purified CD4(+)CD25(+) T reg cells. Moreover, PGE(2) induces a regulatory phenotype in CD4(+)CD25(-) T cells. PGE(2)-treated T cell-mediated inhibition of anti-CD3-stimulated lymphocyte proliferation did not require cell contact. Phenotypic analysis revealed that PGE(2) diminished CD25 expression in both CD4(+)CD2(dim) T cells and CD4(+)CD25(bright) T reg cells. PGE(2) exposure induced the T reg cell-specific transcription factor forkhead/winged helix transcription factor gene (FOXP3) in CD4(+)CD25(-) T cells and significantly up-regulated its expression in CD4(+)CD25(+) T reg cells. Similarly, 24-h incubation with supernatants from cyclooxygenase-2-overexpressing lung cancer cells that secrete high levels of PGE(2) significantly induced FOXP3 in CD4(+)CD25(-) T cells. Finally, PGE(2) up-regulated FOXP3 at both mRNA and protein levels and enhanced FOXP3 promoter activity. This is the first report indicating that PGE(2) can modulate FOXP3 expression and T reg function in human lymphocytes.
引用
收藏
页码:1483 / 1490
页数:8
相关论文
共 50 条
[1]  
ANASTASSIOU ED, 1992, J IMMUNOL, V148, P2845
[2]   Prostaglandin E2-dependent enhancement of tissue inhibitors of metalloproteinases-1 production limits dendritic cell migration through extracellular matrix [J].
Baratelli, FE ;
Heuzé-Vourc'h, N ;
Krysan, K ;
Dohadwala, M ;
Riedl, K ;
Sharma, S ;
Dubinett, SM .
JOURNAL OF IMMUNOLOGY, 2004, 173 (09) :5458-5466
[3]   In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines [J].
Barrat, FJ ;
Cua, DJ ;
Boonstra, A ;
Richards, DF ;
Crain, C ;
Savelkoul, HF ;
de Waal-Malefyt, R ;
Coffman, RL ;
Hawrylowicz, CM ;
O'Garra, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) :603-616
[4]   A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes [J].
Bassuny, WM ;
Ihara, K ;
Sasaki, Y ;
Kuromaru, R ;
Kohno, H ;
Matsuura, N ;
Hara, T .
IMMUNOGENETICS, 2003, 55 (03) :149-156
[5]   The interleukin (IL)-2 family cytokines: Survival and proliferation signaling pathways in T lymphocytes [J].
Benczik, M ;
Gaffen, SL .
IMMUNOLOGICAL INVESTIGATIONS, 2004, 33 (02) :109-142
[6]   Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells [J].
Bensinger, SJ ;
Walsh, PT ;
Zhang, JD ;
Carroll, M ;
Parsons, R ;
Rathmell, JC ;
Thompson, CB ;
Burchill, MA ;
Farrar, MA ;
Turka, LA .
JOURNAL OF IMMUNOLOGY, 2004, 172 (09) :5287-5296
[7]   PGE2 suppresses mitogen-induced Ca2+ mobilization in T cells [J].
Choudhry, MA ;
Hockberger, PE ;
Sayeed, MM .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1999, 277 (06) :R1741-R1748
[8]   ROLE OF CA2+ IN PROSTAGLANDIN E(2)-INDUCED T-LYMPHOCYTE PROLIFERATIVE SUPPRESSION IN SEPSIS [J].
CHOUDHRY, MA ;
AHMAD, S ;
SAYEED, MM .
INFECTION AND IMMUNITY, 1995, 63 (08) :3101-3105
[9]   Prostaglandin E2 down-regulation of T cell IL-2 production is independent of IL-10 during gram-negative sepsis [J].
Choudhry, MA ;
Ahmad, S ;
Ahmed, Z ;
Sayeed, MM .
IMMUNOLOGY LETTERS, 1999, 67 (02) :125-130
[10]  
Choudhry MA, 1998, J IMMUNOL, V160, P929